| Trial Identifier: | 13849 |
| Sponsor: | Eli Lilly and Company |
| Start Date: | April 2012 |
| Primary Completion Date: | July 2014 |
| Study Completion Date: | October 2024 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Results Plain Language Summary - English Version |
| Country | Location |
|---|---|
| Australia, New South Wales | St. Leonards, New South Wales, Australia, 2065 |
| Australia, Victoria | Heidelberg, Victoria, Australia, 3084 |
| Australia, Victoria | Parkville, Victoria, Australia, 3050 |
| Belgium | Edegem, Belgium, 2650 |
| Belgium | Gent, Belgium, 9000 |
| Belgium | Liège, Belgium, 4000 |
| Canada, Ontario | Toronto, Ontario, Canada, M5G 2M9 |
| Canada, Quebec | Montreal, Quebec, Canada, H2L 4M1 |
| France | Bobigny, France, 93009 |
| France | Lyon, France, 69394 |
| France | Marseille, France, 13385 |
| France | Nancy, France, 54035 |
| France | Paris, France, 75651 |
| Germany | Bonn, Germany, 53105 |
| Germany | Frankfurt, Germany, 60596 |
| Germany | Hamburg, Germany, 20246 |
| Germany | Heidelberg, Germany, 69120 |
| Italy | Bologna, Italy, 40139 |
| Italy | Terni, Italy, 05100 |
| Italy | Udine, Italy, 33100 |
| Poland | Lodz, Poland, 93-509 |
| Spain | Barcelona, Spain, 08035 |
| United States, AL | Birmingham, AL, United States, 35294 |
| United States, CA | La Jolla, CA, United States, 92093 |
| United States, CA | San Francisco, CA, United States, 94143 |
| United States, OH | Cleveland, OH, United States, 44195 |
| United States, TX | Dallas, TX, United States, 75246 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company